CEU Statement: Weight and contraception

Statement from the Faculty of Sexual and Reproductive Health's Clinical Effectiveness Unit on weight and contraception.

Quick Starting Contraception

This update of the 2010 Quick Starting Contraception guideline has been developed by the FSRH and brings together evidence and expert opinion on the provision of contraception to women at any time in their cycle.

Effectiveness of ulipristal acetate

Journal of Obstetrics and Gynaecology Research. Conference: 25th Asian and Oceanic Congress of Obstetrics and Gynaecology. Hong Kong. 43 (pp 89-90), 2017.

Audit of women, receiving ulipristal acetate as 1st line (EC) was compared to a retrospective audit of women who received levonorgestrel as 1st line. Results: 662 women received ulipristal acetate, 1 required a TOP. 1397 received levonorgestrel of which 5 required TOP. This is shown below in the table with the failure rate. [TABLE PRESENTED] The odds ratio (of the failure rates) between ulipristal acetate compared to levonorgestrel is 0.50. (Calculation: Odds Ratio = 0.0015106 / 0.0030157 = 0.50091189). Conclusion: This demonstrates that the change in faculty guidance is justified and data from studies suggesting ulipristal acetate is more effective than levonorgestrel is reflected in clinical practice.

UHCW Research: Rimmer M

CEU Clinical Guidance: Emergency Contraception

This document updates previous Faculty of Sexual & Reproductive Healthcare (FSRH) guidance and aims to summarise the available evidence on emergency contraception (EC). The guidance is intended for use by health professionals providing EC.

Contraception, autism and breast cancer

Answer to the question, What would be the best contraception to advise a 15 year old autistic girl with a strong family history of breast cancer to use?, posted to the RCOG Query Bank.

CEU Clinical Guidance: Contraception After Pregnancy

Contraception After Pregnancy aims to guide healthcare professionals to inform and support the women in their care to make planned choices about future pregnancies and improve maternal and child outcomes through optimum spacing between children.

CEU Statement: Combined hormonal contraception and venous thromboembolism

Statement from the Faculty of Sexual and Reproductive Healthcare of the Royal College of Obstetricians and Gynaecologists' Clinical Effectiveness Unit about some fatal cases of venous thrombosis that were associated with use of combined hormonal contraception.

Sexual and reproductive health in England: local and national data

This information provides an overview of the information available on sexually transmitted infection (STIs), HIV, contraception, conception and abortion and where to access it. It is divided into indicators (used for tracking progress), detailed local information (collation and interpretation of local intelligence) and national resources (tables and reports).

Sexual health promotion and contraceptive services in local authorities: A systematic review of economic evaluations 2010-2015

Since 2013, health commissioners in England’s local authorities have been responsible for sexual health services, including contraception, HIV testing, STI testing and treatment, health education and specialist sexual health services. Effective commissioning requires information to indicate which interventions may, or may not, be cost-effective. However, current UK guidance and recent research on the cost-effectiveness of sexual health services provides patchy and fragmented evidence. This study aims systematically to review the evidence available on the cost-effectiveness of OECD-based interventions relevant to UK local authority-commissioned sexual health services.

Contraception Quality Standard

NICE has published a Quality Standard on contraception.

Extrauterine Mirena - conservative or laparoscopic removal?

Answer to the question, A 54 years old asymptomatic postmenopausal patient has missing threads of a Mirena IUS inserted over 9 years ago for heavy periods. Recent ultrasound showed no intrauterine device and plain X-ray showed IUS in pelvis suggesting perforation. Should management be conservative or laparoscopic removal of the device?, posted to the RCOG Query Bank.